Earlier this month, an “IT security issue” cost Indian pharmaceutical Sun Pharmaceutical Industries Ltd. (SUN.NS) income and expenditures.
Sun Pharma said late Sunday that the intrusion breached several file systems and stole some commercial and personal data. It said a ransomware outfit took responsibility.
Sun Pharma, which makes Revital vitamins and Volini painkillers, reported a near 14% increase in total revenue from operations to 112.41 billion rupees ($1.37 billion) in the latest quarter.
On March 2, the pharmaceutical notified the information security issue, which did not affect operations. However, on Sunday, the business stated its containment procedures had hampered operations.
Sun Pharma used specialists and “improved” security to fix the problem.
The corporation couldn’t predict negative effects like greater costs and lawsuits.
Comment Template